Herbal medicines provide regulation against iron overload in cardiovascular diseases: Informing future applications

Jia Liu1, Liangyan Deng1, Liping Qu1

  • 1State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, PR China.

PubMed

Insights

Iron overload impacts cardiovascular diseases (CVD) by promoting ferroptosis. Herbal medicines, particularly flavonoids, show promise in chelating iron and protecting against CVD by modulating key cellular pathways.

Area of Science:

  • Cardiovascular Research
  • Nutritional Science
  • Pharmacology

Background:

  • Iron is vital for cardiomyocytes, but overload or deficiency significantly impacts cardiovascular diseases (CVD).
  • Iron overload contributes to doxorubicin (DOX) cardiomyopathy, atherosclerosis, and myocardial ischemia-reperfusion injury (MI/RI) via lipid peroxide production.
  • Iron overload-induced cell death is a potential mechanism for ferroptosis, a specific form of regulated cell death.

Purpose of the Study:

  • To outline iron metabolism and ferroptosis in cardiomyocytes.
  • To review herbal medicines and extracts for preventing iron overload in CVD.

Main Methods:

  • Systematic literature search across major scientific databases (ScienceDirect, PubMed, Google Scholar, Web of Science).
  • Inclusion of data from Chinese databases (CNKI, WanFang), classic books, and clinical reports.
  • Analysis of collected information on iron metabolism, ferroptosis, and herbal interventions in CVD.

Main Results:

  • Various herbal medicines, including Chinese herbal prescriptions (e.g., Salvia miltiorrhiza injection, Gegen Qinlian decoction) and extracts (flavonoids, terpenoids, polyphenols), demonstrate therapeutic potential.
  • Flavonoids are highlighted for their potent iron-chelating properties.
  • Herbal medicines modulate Nrf2, AMPK, and KAT5/GPX4 signaling pathways to reduce iron overload and lipid peroxidation in CVD.

Conclusions:

  • Herbal medicines offer cardiovascular protection by modulating iron overload and ferroptosis.
  • These natural compounds serve as promising templates for developing strategies to prevent iron overload in CVD.
Abstract

Related Concept Videos

Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.8K
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
588
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
431
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
381
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.4K
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
590